Catalyst Wire Dossier Catalyst Wire Dossier

Rebamipide Eye Drops

rebamipide · Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rebamipide Eye Drops, covering 2006-11-02 to 2008-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Study of Rebamipide Eye Drops to Treat Dry Eye [Phase 3]

See pricing